DOCS analyst estimates
Doximity (DOCS) analyst ratings, the average price target and its range, and every firm's latest call.
DOCS analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 16, 2026 | Raymond James | Raymond James on Doximity Inc (DOCS) Court Filing: 'we see this as a potential positive' | $38.00 |
| Sep 29, 2026 | Evercore ISI | Doximity price target lowered to $35 from $40 at Evercore ISI | $35.00 |
| Sep 8, 2026 | Stifel Nicolaus | Freedom Capital Downgrades Doximity Inc (DOCS) to Hold | $27.00 |
| Aug 13, 2026 | Truist Financial | Doximity Inc (DOCS) PT Raised to $24 at Truist Securities | $24.00 |
| Aug 7, 2026 | Canaccord Genuity | Doximity price target raised to $36 from $30 at Canaccord | $36.00 |
| Aug 7, 2026 | BMO Capital | Doximity price target raised to $30 from $20 at BMO Capital | $30.00 |
| Aug 7, 2026 | Evercore ISI | Doximity price target raised to $40 from $22 at Evercore ISI | $40.00 |
| Aug 7, 2026 | Needham | Doximity price target raised to $41 from $27 at Needham | $41.00 |
| May 14, 2026 | Goldman Sachs | Doximity price target lowered to $24 from $28 at Goldman Sachs | $24.00 |
| May 14, 2026 | Canaccord Genuity | Doximity price target lowered to $30 from $34 at Canaccord | $30.00 |
| May 14, 2026 | Mizuho Securities | Doximity price target lowered to $26 from $34 at Mizuho | $26.00 |
| May 14, 2026 | Needham | Doximity price target lowered to $27 from $55 at Needham | $27.00 |
| May 14, 2026 | BMO Capital | Doximity price target lowered to $20 from $25 at BMO Capital | $20.00 |
| May 14, 2026 | Truist Financial | Doximity price target lowered to $19 from $29 at Truist | $19.00 |
| May 14, 2026 | Barclays | Doximity downgraded to Equal Weight from Overweight at Barclays | $20.00 |
- 21 firms rate DOCS: 7 buy, 12 hold, 2 sell.
- The average price target is $30.10 from 10 analysts, from $20.00 to $41.00.
Updated 2026-11-07 11:50 UTC